Joel Gruchot

664 total citations
21 papers, 340 citations indexed

About

Joel Gruchot is a scholar working on Neurology, Plant Science and Molecular Biology. According to data from OpenAlex, Joel Gruchot has authored 21 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 9 papers in Plant Science and 8 papers in Molecular Biology. Recurrent topics in Joel Gruchot's work include Neuroinflammation and Neurodegeneration Mechanisms (11 papers), Chromosomal and Genetic Variations (7 papers) and Neurogenesis and neuroplasticity mechanisms (6 papers). Joel Gruchot is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (11 papers), Chromosomal and Genetic Variations (7 papers) and Neurogenesis and neuroplasticity mechanisms (6 papers). Joel Gruchot collaborates with scholars based in Germany, Switzerland and Australia. Joel Gruchot's co-authors include Patrick Küry, David Kremer, Peter Göttle, Hans‐Peter Hartung, Moritz Förster, Hervé Perron, Urs Meyer, Luke M. Healy, Ulrike Weber‐Stadlbauer and Christina Volsko and has published in prestigious journals such as Proceedings of the National Academy of Sciences, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Joel Gruchot

21 papers receiving 335 citations

Peers

Joel Gruchot
Joel Gruchot
Citations per year, relative to Joel Gruchot Joel Gruchot (= 1×) peers Benjamin Renouf

Countries citing papers authored by Joel Gruchot

Since Specialization
Citations

This map shows the geographic impact of Joel Gruchot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Gruchot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Gruchot more than expected).

Fields of papers citing papers by Joel Gruchot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Gruchot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Gruchot. The network helps show where Joel Gruchot may publish in the future.

Co-authorship network of co-authors of Joel Gruchot

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Gruchot. A scholar is included among the top collaborators of Joel Gruchot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Gruchot. Joel Gruchot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dietrich, Michael, Joel Gruchot, Christina Hecker, et al.. (2025). Positive allosteric modulation of AMPA receptors via PF4778574 leads to reduced demyelination and clinical disability in experimental models of multiple sclerosis. Frontiers in Immunology. 16. 1532877–1532877. 1 indexed citations
2.
Mueller, Flavia S., Sina M. Schalbetter, Joel Gruchot, et al.. (2025). Recapitulation and reversal of neuropsychiatric phenotypes in a mouse model of human endogenous retrovirus type W expression. Molecular Psychiatry. 30(7). 3325–3337. 1 indexed citations
3.
Gruchot, Joel, Daniel Picard, Hervé Perron, et al.. (2024). HERV-W envelope protein is present in microglial cells of the human glioma tumor microenvironment and differentially modulates neoplastic cell behavior. Microbes and Infection. 27(5-6). 105460–105460. 2 indexed citations
4.
Gruchot, Joel, et al.. (2024). Molecular dissection of HERV-W dependent microglial- and astroglial cell polarization. Microbes and Infection. 27(5-6). 105382–105382. 3 indexed citations
5.
Gruchot, Joel, et al.. (2024). Human endogenous retrovirus type-W and multiple sclerosis–related smoldering neuroinflammation. Neural Regeneration Research. 20(3). 813–814. 1 indexed citations
6.
Pretz, Dominik, Philip M. Heyward, Jeremy Krebs, et al.. (2023). A dahlia flower extract has antidiabetic properties by improving insulin function in the brain. PubMed. 2(4). load026–load026. 2 indexed citations
7.
Gruchot, Joel, Michael Dietrich, Christina Hecker, et al.. (2023). Transgenic expression of the HERV-W envelope protein leads to polarized glial cell populations and a neurodegenerative environment. Proceedings of the National Academy of Sciences. 120(38). e2308187120–e2308187120. 19 indexed citations
8.
Gliem, Michael, Frank Kirchhoff, Joel Gruchot, et al.. (2023). A Novel Ex Vivo Model to Study Therapeutic Treatments for Myelin Repair following Ischemic Damage. International Journal of Molecular Sciences. 24(13). 10972–10972. 1 indexed citations
9.
Göttle, Peter, Janos Groh, Joel Gruchot, et al.. (2023). Teriflunomide as a therapeutic means for myelin repair. Journal of Neuroinflammation. 20(1). 7–7. 9 indexed citations
10.
Pfeuffer, Steffen, Thomas Müntefering, Leoni Rolfes, et al.. (2022). Deficiency of the Two-Pore Potassium Channel KCNK9 Impairs Intestinal Epithelial Cell Survival and Aggravates Dextran Sodium Sulfate-Induced Colitis. Cellular and Molecular Gastroenterology and Hepatology. 14(6). 1199–1211. 2 indexed citations
11.
Gruchot, Joel, et al.. (2022). Interplay between activation of endogenous retroviruses and inflammation as common pathogenic mechanism in neurological and psychiatric disorders. Brain Behavior and Immunity. 107. 242–252. 23 indexed citations
12.
Mueller, Flavia S., et al.. (2022). Susceptibility and resilience to maternal immune activation are associated with differential expression of endogenous retroviral elements. Brain Behavior and Immunity. 107. 201–214. 13 indexed citations
13.
Schira‐Heinen, Jessica, Seul Ki Han, Joel Gruchot, et al.. (2022). Myelin repair is fostered by the corticosteroid medrysone specifically acting on astroglial subpopulations. EBioMedicine. 83. 104204–104204. 8 indexed citations
14.
Göttle, Peter, Luke M. Healy, Rainer Akkermann, et al.. (2021). Identification of novel myelin repair drugs by modulation of oligodendroglial differentiation competence. EBioMedicine. 65. 103276–103276. 23 indexed citations
16.
Küry, Patrick, Joel Gruchot, & David Kremer. (2019). Human endogenous retroviruses: ammunition for myeloid cells in neurodegenerative diseases?. Neural Regeneration Research. 15(6). 1043–1043. 4 indexed citations
17.
Kremer, David, Joel Gruchot, Peter Göttle, et al.. (2019). pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis. Proceedings of the National Academy of Sciences. 116(30). 15216–15225. 86 indexed citations
18.
Gruchot, Joel, David Kremer, & Patrick Küry. (2019). Neural Cell Responses Upon Exposure to Human Endogenous Retroviruses. Frontiers in Genetics. 10. 655–655. 21 indexed citations
19.
Gruchot, Joel, Peter Göttle, Moritz Förster, et al.. (2019). The Molecular Basis for Remyelination Failure in Multiple Sclerosis. Cells. 8(8). 825–825. 80 indexed citations
20.
Göttle, Peter, Moritz Förster, Joel Gruchot, et al.. (2018). Rescuing the negative impact of human endogenous retrovirus envelope protein on oligodendroglial differentiation and myelination. Glia. 67(1). 160–170. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026